MOLOGEN Competitors and Similar CompaniesClear all
KemPharm's competitors and similar companies include Advaxis.
 KemPharm KemPharm is a biopharmaceutical company focused on the discovery and development of new, safer therapies in the areas of pain, ADHD, and other CNS diseases. | ||
Founding Date | Founding Date 2006 | Founding Date 2002 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Kissimmee, US HQ Blacksburg, US Coralville, US Coralville, US | Locations Princeton, US HQ |
Employees | Employees 333% increase | Employees 3540% decrease |
Valuation ($) | Valuation ($) 200.5 m | Valuation ($) 2.4 m |
Financial | ||
Revenue (est.) | Revenue (est.) $106.5m (FY, 2025) | Revenue (est.) $13k (FY, 2023) |
Net income | Net income $83.2m (FY, 2025) | Net income ($48.1m) (FY, 2023) |
For sources of this data, please see the company profile
View Company Profiles
Advaxis
HQ
Princeton, US
Employees
35↓ 40% decrease
Advaxis is a biotechnology company developing the next generation of cancer immunotherapies.
View company